Skip to main content

Table 1 Characteristics of the clinical isolates

From: Carbon monoxide releasing molecule-2 (CORM-2) inhibits growth of multidrug-resistant uropathogenic Escherichia coli in biofilm and following host cell colonization

Isolate CTX-M subgroup CTX-M type ST131 clone Antibiotic resistance
ESBL 1 CTX-M -9 CTX-M-24 - CTX, CAZ, CTB, CIP, GEN, MEL, TMP
ESBL 6 CTX-M -1 CTX-M-15 + CTX, CAZ, CTB, CIP, TMP
ESBL 7 CTX-M -1 CTX-M-15 + CTX, CAZ, CIP, MEL, TMP
ESBL 9 CTX-M -9 CTX-M-14 - CTX, CAZ, CIP, MEL, TMP
UPEC 2a     
UPEC 3a     
UPEC 4a     TMP
UPEC 5a     CIP
  1. Antibiotic resistance of ESBL-producing isolates (ESBL) and non-ESBL-producing UPEC isolates (UPEC) isolated from urine of patients with UTI. The CTX-M subgroup, CTX-M type and sequence type (ST) 131 are indicated for the ESBL-producing isolates
  2. Abbreviations: cefotaxime (CTX), ceftazidime (CAZ), ceftibuten (CTB), ciprofloxacin (CIP), gentamicin (GEN), mecillinam (MEL), nitrofurantoin (NIT), trimethoprim (TMP)
  3. asusceptibility tested for NIT, MEL, TMP, CTX, CIP